Quest Diagnostics OVA1 Blood Test Available for Pre-surgical Ovarian Cancer Evaluation

OVA1, the first blood test cleared by the FDA for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics.

 

The StatSpin CritSpin is a compact, quiet, microhematocrit system which provides complete cell packing in only 2 minutes. It is perfect for the office, laboratory or clinic… anywhere fast, accurate and cost effective microhematocrits are required. Featuring a new easy–to–use Digital Reader, it offers a 2 minute spin, complete cell packing – Meets NCCLS standards – Read tubes in the rotor, less handling, less risk – Digital HCT display reduces chance of error.

 

For further information please visit us at www.statspin.com or call (800) 782–8774.

New Genetic Test Helps Predict Frequency Of Genital Herpes Outbreaks

DermaGenoma Inc released the HerpesDX genetic test, a screening tool to help doctors assess patients risk for developing frequent Genital Herpes (HSV-2) outbreaks.

New BloodCenter of Wisconsin Assay Diagnoses ADAMTS13 Antibodies

BloodCenter of Wisconsins Diagnostic Laboratories announced the availability of a new test for ADAMTS13 antibodies to aid in the diagnosis of thrombotic thrombocytopenic purpura.

Clinical Utility of DiagnoCure's PCA3 Prostate Cancer Marker Confirmed

DiagnoCure Inc announced that the clinical utility of the PROGENSA PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline s REDUCE trial of dutasteride.

Quest Diagnostics, Surescripts to Combine Lab and Prescription Information

Two of the nation's largest healthcare information networks, Quest Diagnostics and Surescripts announce an agreement to pioneer the formation of an integrated service to make laboratory and prescription information broadly and easily accessible to physicians.

Chronix Biomedicals Serum DNA Assays Detect Early-Stage Breast Cancer

Chronix Biomedical announced publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer.

Kalorama Report: Selective Automation a Must for Clinical Labs to Remain Competitive

While clinical laboratories are vital to the diagnostic industry, they are facing multiple challenges that will require increased automation in order for them to remain competitive.

Roche Purchases Microarray Instrument from BioMicro Systems

Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.

Biosearch Technologies Expands Licensing of Roche Patents

Biosearch Technologies Inc announced that the company has expanded its licenses from Roche Molecular Systems.

Want to learn about the benefits and major tax break incentives the American Recovery & Reinvestment Act provides for clinical labs?

Get answers to your questions by visiting CLP's Expert Insight and discover free professional advice that can help you make better, more informed decisions about Lab Information Systems.